AGP Executive Report
Last update: 6 hours agoAir Travel Health Incident: Jet2 Flight LS1413 from London Stansted to Burgas was diverted to Frankfurt after a “medical incident on board,” with refuelling and an arrival about 1h45 late. Cancer Drug Pricing Policy: A Lancet study warns the proposed US Medicare “Most-Favoured-Nation” pricing plan (GLOBE/GUARD) could backfire by pushing manufacturers to raise prices outside the US or delay launches worldwide. Cancer Risk Litigation in Germany’s Orbit: Bayer/Monsanto urged a Missouri judge to approve a $7.25bn Roundup settlement, arguing there’s no other way to resolve ongoing cancer claims; the judge is weighing fairness. Fitness & Cardio Testing: Nashville’s PRO2COL is expanding access to VO₂ max testing, positioning it as an objective measure of cardiorespiratory fitness linked to cardiovascular risk. Regenerative Medicine R&D: NurExone and NanoPass plan to evaluate MicronJet delivery for exosome eye/skin therapies in preclinical work. Medical Device Update (Germany): Zeiss AT Lucia toric IOL (bitoric hydrophobic monofocal) is reported to show good rotational stability and visual outcomes after launch in Germany. Sports Hygiene Policy: HYROX co-founder Moritz Fürste apologized after delayed response to an athlete’s bowel incontinence in Beijing, with revised procedures introduced.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
